Table 2 Laboratory data of Gitelman-like syndrome patients after cisplatin treatment.

1988 ⁽³⁾

22/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.4

8.9^■

0.9^■

88

2–6^◆¤

1988 ⁽³⁾

36/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.2

8.9^■

0.9^■

100

2–6^◆¤

1988 ⁽³⁾

39/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.1

8.9^■

0.9^■

117

2–6^◆¤

1988 ⁽³⁾

25/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.4

8.9^■

0.9^■

69

2–6^◆¤

1988 ⁽³⁾

27/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.1

8.9^■

0.9^■

105

2–6^◆¤

1988 ⁽³⁾

24/M

Testicular

459–954^◆¤

3.4–3.9^◆ψ

1.6

8.9^■

0.9^■

85

2–6^◆¤

1990 ⁽⁴⁾

8.5/M

Neuroblastoma

720

3.4

1.6

5.5

0.2

85

1.5

1990 ⁽⁴⁾

11/F

Neuroblastoma

1,710

3.7

1.8

3.4

0.1

102

3.5

1990 ⁽⁴⁾

8/M

Neuroblastoma

630

3.6

1.2

8.3

0.2

79

1

1991 ⁽⁵⁾

13* (4 patients)

Neuroblastoma Sarcomas

310–1,710^◆¤

3.2 ^♣

1.4^♣

4.3^■

0.42^■

85^■

1.5*

Our case

42/F

Ovarian

No data

3.4^◇

1.3^◇

8.5

0.6

80

20

Mean +/- SD

21.0 + 11.1

872 +280

3.4 +0.1

1.4 +0.2

6.9 +2.2

0.6 +0.3

89 +12

3.8 +4.5